RecruitingPhase 4NCT04729686

The Pericapsular Nerve Block in Total Hip Arthroplasty

The Pericapsular Nerve Block in Total Hip Arthroplasty: A Randomized, Controlled Trial


Sponsor

LifeBridge Health

Enrollment

78 participants

Start Date

Dec 9, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria6

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Planned primary total hip arthroplasty with anterior (Smith-Peterson) approach
  • ASA score of 1 to 3
  • Indicated for one of the two nerve block groups
  • Must be opioid naïve at screening as defined by the FDA - According to the Food and Drug Administration, opioid-tolerant patients were those currently receiving or who had previously received 60 mg PO morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg PO oxycodone per day, 8 mg PO hydromorphone per day, 25 mg PO oxymorphone per day, 60 mg PO hydrocodone per day, or an equivalent dose of another opioid for a duration of one week or longer (16)

Exclusion Criteria7

  • Current or previous diagnosis of "chronic pain"
  • Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.)
  • Diagnosis of ankylosing spondylitis
  • Allergy to any potential medications utilized in any of the two groups
  • Conversion of patient to general anesthesia intraoperatively
  • Treatment with another investigational drug or other intervention for pain
  • Any condition(s) or diagnosis, both physical or psychological, or physical exam finding in the opinion of the investigator that would precludes participation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPericapsular Nerve Block

Per Standard Institutional Practice

DRUGFascia Iliaca Nerve Block

Per Standard Institutional Practice


Locations(1)

Sinai Hospital of Baltimore

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04729686


Related Trials